VIJU VIJAYSADAN: Open Payments
NPI 1538110754 · KINNELON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$76,357 in 263 payments from 30 companies in 2025. Trend: 2023 $71,698 · 2024 $143,901 · 2025 $76,357
Speaker / faculty: $61,570Travel & lodging: $8,712Food & beverage: $6,059Education: $16
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 107 | $74,048 |
| Axsome Therapeutics, Inc. | 24 | $424 |
| Bayer Healthcare Pharmaceuticals Inc. | 16 | $323 |
| Mannkind Corporation | 38 | $312 |
| Amgen Inc. | 16 | $232 |
| PFIZER INC. | 12 | $169 |
| Viatris Specialty LLC | 8 | $139 |
| Cumberland Pharmaceuticals, Inc. | 4 | $73 |
| Merck Sharp & Dohme LLC | 4 | $67 |
| Corcept Therapeutics | 4 | $66 |
Products named: BREZTRI, AIRSUPRA, Auvelity, Kerendia, AFREZZA, OTEZLA, FARXIGA, YUPELRI.
Industry payments across NJ — which companies pay providers there.
